Taikang Asset Management (HK)’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Taikang Asset Management (HK)’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$333K	Hold	170,931	–	–	0.03%	77
2026 Q1	$420K	Buy	170,931 +42,166	+33%	+$141K	0.04%	72
2025 Q4	$512K	Buy	+128,765	New	+$570K	0.05%	104

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Taikang Asset Management (HK)'s NBP Position: Q2 2026 in Review

Taikang Asset Management (HK) held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q2 2026 at 170,931 shares worth $333K. The position accounts for 0.03% of the portfolio, ranked #77.

Taikang Asset Management (HK) first reported a position in NBP in Q4 2025 and has held it in 3 quarters since. The position peaked at $512K in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Taikang Asset Management (HK) held 170,931 shares of NovaBridge Biosciences American Depositary Shares worth $333K as of Q2 2026.
Taikang Asset Management (HK) left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q2 2026.
NovaBridge Biosciences American Depositary Shares made up 0.03% of Taikang Asset Management (HK)'s portfolio in Q2 2026, its #77 holding.
Taikang Asset Management (HK) first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2025 and has held it in 3 quarters since.
Taikang Asset Management (HK)'s NovaBridge Biosciences American Depositary Shares position peaked at $512K in Q4 2025.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Taikang Asset Management (HK)'s 13F filing for Q2 2026, filed 12 Aug 2026.